ROBERT JOHNSON: Open Payments
NPI 1992499024 · ROANOKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,245 in 79 payments from 14 companies in 2025. Trend: 2023 $186 · 2024 $1,527 · 2025 $1,245
Food & beverage: $1,245
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $395 |
| Novo Nordisk Inc | 12 | $228 |
| AstraZeneca Pharmaceuticals LP | 11 | $193 |
| Lilly USA, LLC | 9 | $112 |
| PFIZER INC. | 4 | $79 |
| Corcept Therapeutics | 2 | $45 |
| Lundbeck LLC | 2 | $43 |
| Medtronic, Inc. | 2 | $43 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
Products named: VRAYLAR, FARXIGA, MOUNJARO, Rybelsus, Ozempic, Wegovy, QULIPTA, BREZTRI.
Industry payments across VA — which companies pay providers there.
